Executive Series - Circadian Technologies (CIR) CEO and Managing Director, Dr Megan Baldwin
CommSec’s Tom Piotrowski speaks with Circadian Technologies (CIR) CEO and Managing Director, Dr Megan Baldwin about the company’s lead molecule OPT-302 drug.
CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...
Expertise
No areas of expertise
most popular
Equities
The quirky trend to add to your recession ready portfolio
Sara Allen,
Livewire Markets
Equities
Signs of the bottom
Ally Selby,
Livewire Markets
Equities
Rudi: The ASX ‘looks’ like a bargain hunter’s paradise
James Marlay,
Livewire Markets